Articles with "biologic" as a keyword



Photo by dawson2406 from unsplash

Efficacy of biologics for the treatment of periodontal infrabony defects: An American Academy of Periodontology best evidence systematic review and network meta-analysis.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of periodontology"

DOI: 10.1002/jper.22-0120

Abstract: BACKGROUND A large variety of biomaterials, biologics and membranes have been utilized in the past 40 years for the regenerative treatment of periodontal infrabony defects. Biologic agents have progressively gained popularity among clinicians and are… read more here.

Keywords: biologic; periodontology; analysis; treatment ... See more keywords
Photo by smallcamerabigpictures from unsplash

Biologic Grafts for Use in Pelvic Organ Prolapse Surgery: a Contemporary Review

Sign Up to like & get
recommendations!
Published in 2020 at "Current Urology Reports"

DOI: 10.1007/s11934-020-01013-x

Abstract: Pelvic organ prolapse (POP) is a common condition and there is a plethora of surgical techniques available to address this problem. We present a review of biologic grafts, including the latest literature to help guide… read more here.

Keywords: organ prolapse; pelvic organ; biologic; biologic grafts ... See more keywords
Photo by myriamzilles from unsplash

Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad

Sign Up to like & get
recommendations!
Published in 2017 at "Immunologic Research"

DOI: 10.1007/s12026-016-8833-7

Abstract: Increasing evidence indicates that patients with chronic inflammatory arthritis (CIA), including rheumatoid arthritis and spondyloarthropathies, have an increased risk of arrhythmic events, significantly contributing to the higher cardiovascular disease (CVD) morbidity and mortality observed in… read more here.

Keywords: risk; biologic drugs; biologic; chronic inflammatory ... See more keywords
Photo from wikipedia

Microfluidic-Mediated Self-Assembly of Phospholipids for the Delivery of Biologic Molecules.

Sign Up to like & get
recommendations!
Published in 2021 at "International journal of pharmaceutics"

DOI: 10.1016/j.ijpharm.2021.121347

Abstract: The encapsulation of biologic molecules using a microfluidic platform is a procedure that has been understudied but shows great promise from initial reported studies. The study focusses upon the encapsulation of bovine serum albumin (BSA)… read more here.

Keywords: self assembly; mediated self; microfluidic mediated; assembly phospholipids ... See more keywords
Photo from archive.org

Efficacy of Biologics for Ligamentous and Tendon Healing

Sign Up to like & get
recommendations!
Published in 2020 at "Operative Techniques in Sports Medicine"

DOI: 10.1016/j.otsm.2020.150755

Abstract: The use of “biologics” has become increasingly popular over the past several decades due to their potential to treat various pathologies by providing supraphysiological doses of anabolic growth factors. Within orthopaedic sports medicine, biologic treatments… read more here.

Keywords: medicine; ligamentous tendon; biologic; efficacy biologics ... See more keywords
Photo by philipmyr from unsplash

Torque teno virus viremia in patients with chronicarthritis: Influence of biologic therapies.

Sign Up to like & get
recommendations!
Published in 2019 at "Seminars in arthritis and rheumatism"

DOI: 10.1016/j.semarthrit.2019.06.019

Abstract: OBJECTIVE Torque teno virus (TTV) is a highly prevalent non-pathogenic anellovirus whose plasma levels may be a biomarker of immunosuppression. The aim of this study was to assess whether specific immune-targeting with different biologic drugs… read more here.

Keywords: biologic; torque teno; viremia; teno virus ... See more keywords
Photo from wikipedia

Testing the anti-osteoclastic function of biologic DMARDs

Sign Up to like & get
recommendations!
Published in 2018 at "Nature Reviews Rheumatology"

DOI: 10.1038/s41584-018-0046-0

Abstract: A variety of biologic DMARDs now exist for the treatment of rheumatoid arthritis, but we don’t really know how these drugs function in vivo. Can time-lapse intravital imaging distinguish the modes of action of DMARDs… read more here.

Keywords: biologic dmards; biologic; testing anti; osteoclastic function ... See more keywords
Photo by sharonmccutcheon from unsplash

New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management

Sign Up to like & get
recommendations!
Published in 2018 at "Expert Review of Clinical Immunology"

DOI: 10.1080/1744666x.2018.1454835

Abstract: ABSTRACT Introduction: Biologic drugs have revolutionized the treatment of moderate to severe psoriasis in recent years because of their high efficacy and low risk of toxicity. However, even within the group of biologic therapies, there… read more here.

Keywords: first generation; biologic drugs; biologic; review ... See more keywords
Photo from wikipedia

P008 Improving patient care cost-effectively through a virtual rheumatology biologic clinic

Sign Up to like & get
recommendations!
Published in 2021 at "Rheumatology"

DOI: 10.1093/rheumatology/keab247.007

Abstract: Background/Aims  There are currently around 1,000 rheumatology patients on biologic therapy in the Southern Health and Social Care Trust (SHSCT) with annual growth of > 15%. Challenges facing the Rheumatology Biologics Service include: Continued increase… read more here.

Keywords: care; none; drug; rheumatology ... See more keywords
Photo by anniespratt from unsplash

BioLogic-HD™ and the problem of being (way) too far ahead of the market.

Sign Up to like & get
recommendations!
Published in 2022 at "Artificial organs"

DOI: 10.1111/aor.14181

Abstract: In the 1980s, I led a team to build a hemodialysis machine with sorbent regeneration of dialysate, ultrafiltration control, and single-needle access. The BioLogic-HD™ was perfectly suited for home hemodialysis, but not for in-center or… read more here.

Keywords: biologic problem; market; problem way; dialysis ... See more keywords
Photo from wikipedia

Effectiveness of anti‐interleukin 23 biologic drugs in psoriasis patients who failed anti‐interleukin 17 regimens. A real‐life experience

Sign Up to like & get
recommendations!
Published in 2020 at "Dermatologic Therapy"

DOI: 10.1111/dth.14584

Abstract: Among the most recent biologic drugs available for psoriasis therapy, those targeting interleukin‐17 (secukinumab and ixekizumab) or its receptor (brodalumab) have been shown to be quickly effective. However, in those patients who failed one or… read more here.

Keywords: biologic drugs; biologic; patients failed; psoriasis ... See more keywords